Deutsche Bank Maintains Sell on AstraZeneca PLC (AZN) Feb 2026
Deutsche Bank on February 06, 2026 maintained a Sell rating on AstraZeneca PLC (AZN), while raising its price target to 11,500 GBp. The AZN analyst rating therefore signals continued caution from a major house even as the bank nudged fair value higher. This combination matters because it pairs a conservative recommendation with a slightly higher valuation, creating mixed signals for investors weighing near-term risk against longer-term potential.
Continue Reading on Meyka
This article is available in full on our main platform. Get access to complete analysis, stock insights, and more.
Read Full Article →
